Treating Attention-Deficit/Hyperactivity Disorder Matters

JAMA. 2024 Mar 12;331(10):831-833. doi: 10.1001/jama.2024.1755.

Authors

Frances R Levin^{1

2}, Mariely Hernandez^{1

2}, John J Mariani^{1

2}

Affiliations

¹ Division on Substance Use Disorders, New York State Psychiatric Institute, New York, New York.
² Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Attention Deficit Disorder with Hyperactivity* / drug therapy
Humans

Grants and funding

T32 DA007294/DA/NIDA NIH HHS/United States